Specialty medications — high-cost drugs that treat complex, chronic, or rare conditions — continue to be the primary drivers of...

“Can COVID-19 Cause Diabetes?” “COVID-19 and the potential link to diabetes” “New type 2 diabetes diagnoses in youth climbed 77%...

The primary focus of the employer benefits advisory industry tends to gravitate to the most expensive or new-to-market medication. Why?...

It can be argued that few developments in the history of the pharmacy benefits industry have had as much impact...

In a year of COVID-19 and the race to an effective vaccine, news about several breakthrough treatments for cancer got...

Top Three Things You'll Learn Potential blockbuster specialty drugs in the pipeline for 2021-2022 How the new drugs coming to...

Dispensing a 90-day supply of medications has become a common benefit design in prescription drug programs today. Proponents tout lower costs...

 What You'll Learn Changes in the drug product mix and the impact on pharmacy benefits plan sponsors How specialty...

A generic-first strategy has proven to be a successful strategy used by self-funded employers to manage high prescription drug costs....

 At RxBenefits, we’ve been asked a lot about benefit plan design – copays, tiering, plan exclusions, and more. When...